CLIR
ClearSign Technologies Corporation
There isn't enough reported data to score CLIR yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CLIR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
CLIR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CLIR PE Valuation
CLIR has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CLIR Forward outlook
There aren't enough analyst estimates for CLIR to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CLIR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.97 | +$0.13 |
| Q1 2026 | -$1.05 | +$0.15 |
| Q4 2025 | -$1.06 | +$0.04 |
| Q3 2025 | -$1.20 | $0.00 |
| Q2 2025 | -$1.10 | +$0.20 |
| Q1 2025 | -$1.20 | +$0.10 |
| Q4 2024 | -$1.10 | +$0.30 |
| Q3 2024 | -$1.20 | +$0.20 |
CLIR has the edge over RKLB on earnings, with more consistent year-over-year improvement.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CLIR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $560K | +321% |
| Q1 2026 | $191K | -52% |
| Q4 2025 | $3.7M | +522% |
| Q3 2025 | $1M | -45% |
| Q2 2025 | $133K | +196% |
| Q1 2025 | $401K | -64% |
| Q4 2024 | $590K | -54% |
| Q3 2024 | $1.9M | +2087% |
CLIR's revenue is growing: $560,000 last quarter, up 321% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -268% | +1115 points |
| Q1 2026 | -1193% | -630 points |
| Q4 2025 | -23% | +260 points |
| Q3 2025 | -170% | -93 points |
| Q2 2025 | -1382% | +3367 points |
| Q1 2025 | -563% | -449 points |
| Q4 2024 | -282% | -192 points |
| Q3 2024 | -77% | +1684 points |
CLIR's operating margin was −268% last quarter, up 1114 points from the same quarter a year ago.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB's revenue has grown year over year every quarter since late 2021: $268M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB has the edge over CLIR on profitability, with a higher operating margin.
CLIR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.3M | -$847K |
| Q3 2025 | -$1.8M | -$398K |
| Q1 2025 | -$1.1M | -$114K |
| Q4 2024 | -$436K | +$1M |
| Q4 2023 | -$1.5M | -$717K |
| Q4 2022 | -$733K | +$439K |
| Q3 2022 | -$917K | +$992K |
| Q2 2022 | -$1.8M | +$288K |
CLIR has the stronger cash trend. Its trailing FCF is up 13% versus its history, compared with RKLB at down 85%.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CLIR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.4% | +304K shares |
| 1 year | +7.4% | +410K shares |
| 3 years | +54% | +2.1M shares |
| 5 years | +89% | +2.8M shares |
CLIR has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CLIR Net Leverage
CLIR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLIR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.8 | Neutral |
| Stochastic | 6.6 | Oversold |
CLIR's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CLIR PE vs Industrials Sector
CLIR has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CLIR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.73 | 17% below |
| 20 week MA | $3.48 | 35% below |
| 50 week MA | $4.60 | 51% below |
| 100 week MA | $6.21 | 64% below |
| 200 week MA | $8.03 | 72% below |
CLIR is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over CLIR on trend strength, trading above more of its moving averages.
CLIR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.70 | $33.5 | +335% |
| 2021 | $33.5 | $14.5 | -57% |
| 2022 | $14.5 | $6.40 | -56% |
| 2023 | $6.40 | $11.1 | +73% |
| 2024 | $11.1 | $12.2 | +9.9% |
| 2025 | $12.2 | $6.09 | -50% |
| 2026 YTD | $6.09 | $2.26 | -63% |
CLIR's yearly returns have swung widely, from +335% in 2020 to −57% in 2021. It's down 63% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over CLIR on returns for 2026, with the stronger performance.